Literature DB >> 33996177

Clinical Profile and Outcome of Indian Children with Aromatic L-Amino Acid Decarboxylase Deficiency: A primary CSF Neurotransmitter Disorder Mimicking as Dyskinetic Cerebral Palsy.

Vykuntaraju K Gowda1, Hemadri Vegda1, Balamurugan B Nagarajan1, Sanjay K Shivappa1.   

Abstract

Aromatic L-amino acid decarboxylase (AADC) deficiency is a disorder of neurotransmitter synthesis. It presents with psychomotor delay, dystonia, oculogyric crisis, and autonomic features. There is paucity of literature on this disorder. Hence, we are reporting this series with an objective to study profile and outcome of Indian children with AADC deficiency. In this retrospective review, all case records of genetically confirmed cases of AADC deficiency at the pediatric neurology department in a tertiary care hospital, from March 2014 to March 2020, were analyzed. The data were extracted in a predesigned proforma and analyzed. Out of seven cases, five were males. Median age of onset of symptoms was 4 months but median age of diagnosis was 12 months. All of them had developmental delay, oculogyric crisis, dystonia, increased sweating, intermittent fever, feeding and sleep disturbance, irritability, failure to thrive, axial hypotonia with dyskinetic quadriparesis, and normal magnetic resonance imaging (MRI) of brain and electroencephalogram (EEG). All of them were treated with pyridoxal 5-phosphate, trihexyphenidyl and pramipexole and six cases, in addition, were given bromocriptine. One case was additionally treated with selegiline. One case showed good improvement, five showed partial improvement, and one case expired. In conclusion, AADC deficiency should be suspected in any child with dyskinetic quadriparesis, oculogyric crisis, autonomic disturbances like increased sweating, intermittent fever, and sleep disturbance with normal neuroimaging. Thieme. All rights reserved.

Entities:  

Keywords:  AADC; DDC; dyskinetic; neurotransmitter; oculogyric

Year:  2020        PMID: 33996177      PMCID: PMC8110350          DOI: 10.1055/s-0040-1714690

Source DB:  PubMed          Journal:  J Pediatr Genet        ISSN: 2146-460X


  25 in total

1.  Gene therapy for aromatic L-amino acid decarboxylase deficiency.

Authors:  Wuh-Liang Hwu; Shin-ichi Muramatsu; Sheng-Hong Tseng; Kai-Yuan Tzen; Ni-Chung Lee; Yin-Hsiu Chien; Richard O Snyder; Barry J Byrne; Chun-Hwei Tai; Ruey-Meei Wu
Journal:  Sci Transl Med       Date:  2012-05-16       Impact factor: 17.956

2.  Aromatic amino acid decarboxylase deficiency in twins.

Authors:  K Hyland; P T Clayton
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 3.  Monoamine neurotransmitter disorders--clinical advances and future perspectives.

Authors:  Joanne Ng; Apostolos Papandreou; Simon J Heales; Manju A Kurian
Journal:  Nat Rev Neurol       Date:  2015-09-22       Impact factor: 42.937

4.  Report of two never treated adult sisters with aromatic L-amino Acid decarboxylase deficiency: a portrait of the natural history of the disease or an expanding phenotype?

Authors:  Vincenzo Leuzzi; Mario Mastrangelo; Agata Polizzi; Cristiana Artiola; André B P van Kuilenburg; Carla Carducci; Martino Ruggieri; Rita Barone; Barbara Tavazzi; Nico G G M Abeling; Lida Zoetekouw; Vito Sofia; Mario Zappia; Claudia Carducci
Journal:  JIMD Rep       Date:  2014-05-01

Review 5.  Aromatic amino acid decarboxylase deficiency: Molecular and metabolic basis and therapeutic outlook.

Authors:  Nastassja Himmelreich; Riccardo Montioli; Mariarita Bertoldi; Carla Carducci; Vincenzo Leuzzi; Corinne Gemperle; Todd Berner; Keith Hyland; Beat Thöny; Georg F Hoffmann; Carla B Voltattorni; Nenad Blau
Journal:  Mol Genet Metab       Date:  2019-03-27       Impact factor: 4.797

6.  Aromatic L-amino acid decarboxylase deficiency: clinical features, drug therapy and follow-up.

Authors:  C Manegold; G F Hoffmann; I Degen; H Ikonomidou; A Knust; M W Laass; M Pritsch; E Wilichowski; F Hörster
Journal:  J Inherit Metab Dis       Date:  2009-01-28       Impact factor: 4.982

7.  Natural History of Aromatic L-Amino Acid Decarboxylase Deficiency in Taiwan.

Authors:  Wuh-Liang Hwu; Yin-Hsiu Chien; Ni-Chung Lee; Mei-Hsin Li
Journal:  JIMD Rep       Date:  2017-08-31

Review 8.  The phenotypic spectrum of paediatric neurotransmitter diseases and infantile parkinsonism.

Authors:  R Pons
Journal:  J Inherit Metab Dis       Date:  2008-12-26       Impact factor: 4.982

9.  Efficacy and safety of AAV2 gene therapy in children with aromatic L-amino acid decarboxylase deficiency: an open-label, phase 1/2 trial.

Authors:  Yin-Hsiu Chien; Ni-Chung Lee; Sheng-Hong Tseng; Chun-Hwei Tai; Shin-Ichi Muramatsu; Barry J Byrne; Wuh-Liang Hwu
Journal:  Lancet Child Adolesc Health       Date:  2017-10-23

10.  Gene therapy improves motor and mental function of aromatic l-amino acid decarboxylase deficiency.

Authors:  Karin Kojima; Takeshi Nakajima; Naoyuki Taga; Akihiko Miyauchi; Mitsuhiro Kato; Ayumi Matsumoto; Takahiro Ikeda; Kazuyuki Nakamura; Tetsuo Kubota; Hiroaki Mizukami; Sayaka Ono; Yoshiyuki Onuki; Toshihiko Sato; Hitoshi Osaka; Shin-Ichi Muramatsu; Takanori Yamagata
Journal:  Brain       Date:  2019-02-01       Impact factor: 13.501

View more
  1 in total

Review 1.  Clinical Features in Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: A Systematic Review.

Authors:  Susanna Rizzi; Carlotta Spagnoli; Daniele Frattini; Francesco Pisani; Carlo Fusco
Journal:  Behav Neurol       Date:  2022-10-11       Impact factor: 3.112

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.